Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Issue: Product safety
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 76 - 90 of 109 items.
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Methadone Treatment of Opioid Dependence and Potential Differences in Product Effect
AlertHealth professional risk communication | 2020-03-31
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Cybersecurity vulnerabilities associated with some medical devices with Bluetooth Low Energy chips
AlertInformation update | 2020-03-11
GILENYA (fingolimod) - Risk of Congenital Malformations
AlertHealth professional risk communication | 2019-12-19
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
AlertHealth professional risk communication | 2019-11-04
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
AlertHealth professional risk communication | 2019-10-15
Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
AlertHealth professional risk communication | 2019-10-09
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
AlertInformation update | 2019-09-13
Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching between Different Oral Formulations
AlertHealth professional risk communication | 2019-07-22
Substance use during summer events and festivals
AlertInformation update | 2019-06-20
ALERTEC (modafinil) and the Risk of Congenital Anomalies
AlertHealth professional risk communication | 2019-06-20